Neonatal Abstinence Syndrome
The DOI matches its Crossref record; 181 of the 182 references it cites were found in a registry or an index.
Abstract
Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal exposure to substances that were used or abused by the mother during pregnancy. Withdrawal from licit or illicit substances is becoming more common among neonates in both developed and developing countries. NAS continues to be an important clinical entity throughout much of the world. NAS leads to a constellation of signs and symptoms involving multiple systems. The pathophysiology of NAS is not completely understood. Urine or meconium confirmation may assist the diagnosis and management of NAS. The Finnegan scoring system is commonly used to assess the severity of NAS; scoring can be helpful for initiating, monitoring, and terminating treatment in neonates. Nonpharmacological care is the initial treatment option, and pharmacological treatment is required if an improvement is not observed after nonpharmacological measures or if the infant develops severe withdrawal. Morphine is the most commonly used drug in the treatment of NAS secondary to opioids. An algorithmic approach to the management of infants with NAS is suggested. Breastfeeding is not contraindicated in NAS, unless the mother is taking street drugs, is involved in polydrug abuse, or is infected with HIV. Future studies are required to assess the long-term effects of NAS on children after prenatal exposure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In general, breastfeeding is not contraindicated in the presence of BZD use.190”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [190]
Citations
Cites
The Transfer of Drugs and Other Chemicals Into Human Milk
Committee on Drugs (2001) · Pediatrics · doi:10.1542/peds.108.3.776 · Cited by 1,256
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012) · JAMA · doi:10.1001/jama.2012.3951 · Cited by 907
Hudak, M. L., Tan, R. C., THE COMMITTEE ON DRUGS, THE COMMITTEE ON FETUS AND NEWBORN, Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Neville, K. A., Paul, I. M., Van Den Anker, J. N., et al. (2012) · Pediatrics · doi:10.1542/peds.2011-3212 · Cited by 877
Neonatal abstinence syndrome: assessment and management.
Finnegan, L. P., Connaughton, J. F., Kron, R. E., & Jp, E. (1975) · PubMed · Cited by 664
Prenatal Substance Abuse: Short- and Long-term Effects on the Exposed Fetus
Behnke, M., Smith, V. C., COMMITTEE ON SUBSTANCE ABUSE, COMMITTEE ON FETUS AND NEWBORN, Behnke, M., Smith, V. C., Levy, S., Ammerman, S. D., Gonzalez, P. K., Ryan, S. A., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-3931 · Cited by 604
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics
Sachs, H. C., COMMITTEE ON DRUGS, Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Johnson, T., Neville, K., Paul, I. M., & Van den Anker, J. (2013) · Pediatrics · doi:10.1542/peds.2013-1985 · Cited by 555
Opioid receptors: Distinct roles in mood disorders
Lutz, P.-E., & Kieffer, B. L. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.002 · Cited by 542
Transfer of drugs and other chemicals into human milk
Roberts, R., Blumer, J. L., Gorman, R. L., Lambert, G. H., Rumack, B. H., SNODGRASS, W. T., Bennett, D. R., ', J. C., Petricciani, J. C., Licata, S., et al. (1989) · PEDIATRICS · Cited by 503
Research works printed but not linked: 5
- Menninger-Lerchenthal, 1934, Die morphin kranheit der neugeborenen morphine stischer mutter Monatsschr., F Kinderh., 60, 182
- Earle, 1888, Maternal opium habit and infant mortality., M Standard (Chicago)., 3, 2
- OD, 1903, Fetal morphine addiction, queries and minor notes., JAMA, 40, 1092
- Cunningham, 2010, Teratology and medications that affect the fetus, 328
- ACOG Committee on Practice Bulletins, 2008, ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation., Obstet Gynecol, 111, 1001
Cited by
Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017
Hirai, A. H., Ko, J. Y., Owens, P. L., Stocks, C., & Patrick, S. W. (2021) · JAMA · doi:10.1001/jama.2020.24991 · Cited by 567
McQueen, K., & Murphy-Oikonen, J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600879 · Cited by 324
Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age
Ko, J. Y., Farr, S. L., Tong, V. T., Creanga, A. A., & Callaghan, W. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.03.021 · Cited by 323
An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome
Grossman, M. R., Berkwitt, A. K., Osborn, R. R., Xu, Y., Esserman, D. A., Shapiro, E. D., & Bizzarro, M. J. (2017) · Pediatrics · doi:10.1542/peds.2016-3360 · Cited by 279
Reece-Stremtan, S., Marinelli, K. A., & The Academy of Breastfeeding Medicine (2015) · Breastfeeding Medicine · doi:10.1089/bfm.2015.9992 · Cited by 222
“In addition, about 70% of infants born to women prescribed methadone during pregnancy will experience neo-natal abstinence syndrome (NAS), 23 the constellation of signs and symptoms often presenting following in utero opioid exposure.”
Metadata
- Authors
- Kocherlakota, P.
- Affiliations
- New York Medical College (US)
- Corresponding author
- Kocherlakota, Prabhakar
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2014-08-01
- Volume
- 134
- Issue
- 2
- Pages
- e547-e561
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2117713721
- Cited by
- 612
- References
- 182
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 39 · 2023: 48 · 2022: 43 · 2021: 68 · 2020: 72 · 2019: 93 · 2018: 67 · 2017: 62 · 2016: 25 · 2015: 22 · 2014: 8
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Touro Scholar (Touro College) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and Neonatal Healthcare
- Keywords
- neonatal abstinence syndrome, prenatal drug exposure, drug use in pregnancy, opioid withdrawal, breastfeeding
- MeSH terms
- Animals, Breast Feeding, Female, Humans, Infant, Newborn, Methadone, Neonatal Abstinence Syndrome, Pregnancy, Risk Factors, Opiate Substitution Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neonatal Abstinence Syndrome. https://app.cochat.ai/papers/10.1542/peds.2013-3524
- The paper
- Kocherlakota, P. (2014). Neonatal Abstinence Syndrome. Pediatrics. https://doi.org/10.1542/peds.2013-3524
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.